CD3 (Centre for Drug Design and Discovery) is an investment fund aimed at promoting the discovery and development of medicines for various kinds of diseases. It operates a technology transfer platform focusing on small molecule drug discovery, assay development, HTS, medicinal chemistry, analytical chemistry, and other areas. CD3 aims to help academic institutions and small companies turn their biomedical research into drugs.